Phendimetrazine
- Generic Name
- Phendimetrazine
- Brand Names
- Fendique
- Drug Type
- Small Molecule
- Chemical Formula
- C12H17NO
- CAS Number
- 634-03-7
- Unique Ingredient Identifier
- AB2794W8KV
- Background
Phendimetrazine is a weight loss medication. Phendimetrazine is chemically related to amphetamines and is a Schedule III drug under the Convention on Psychotropic Substances and in the US since 1970.
- Indication
Used in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction.
- Associated Conditions
- Exogenous Obesity
- Associated Therapies
- -
Reinforcing Effects of Cocaine During Phendimetrazine Maintenance
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-08-13
- Last Posted Date
- 2019-07-02
- Lead Sponsor
- William Stoops
- Target Recruit Count
- 30
- Registration Number
- NCT02522325
- Locations
- 🇺🇸
University of Kentucky Department of Behavioral Science, Lexington, Kentucky, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath